Published in Nephrol Dial Transplant on September 01, 1996
Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide. J Toxicol Environ Health B Crit Rev (2007) 1.49
Bullous dermatosis of end-stage renal disease and aluminium. Nephrol Dial Transplant (1997) 0.75
Clinical problem-solving. A leading question. N Engl J Med (1998) 4.10
Glomerular hemodynamics in severe obesity. Am J Physiol Renal Physiol (2000) 2.05
Hepatitis C infection in dialysis patients in Israel. Isr Med Assoc J (2001) 1.46
Effects of fish-oil ingestion on cardiovascular risk factors in hyperlipidemic subjects in Israel: a randomized, double-blind crossover study. Am J Clin Nutr (1990) 1.39
Reflex sympathetic dystrophy of both patellae following burns. Burns (1995) 1.11
The heme biosynthetic pathway in lymphocytes of patients with malignant lymphoproliferative disorders. Cancer Lett (1988) 1.04
The effect of DL-propranolol on delta-aminolevulinic acid synthetase activity and urinary excretion of porphyrins in allylisopropylacetamide-induced experimental porphyria. Biochim Biophys Acta (1973) 0.98
Pseudotumor cerebri and nitrofurantoin. Drug Intell Clin Pharm (1988) 0.98
Effect of cyclosporin A on DNA repair and cancer incidence in kidney transplant recipients. J Lab Clin Med (2001) 0.97
Tubulointerstitial nephritis and uveitis: association with suppressed cellular immunity. Nephrol Dial Transplant (1993) 0.97
Protoporphyrin biosynthesis in melanoma B16 cells stimulated by 5-aminolevulinic acid and chemical inducers: characterization of photodynamic inactivation. Int J Cancer (1994) 0.95
The effects of metalloporphyrins, porphyrins and metals on the activity of delta-aminolevulinic acid synthase in monolayers of chick embryo liver cells. Biochem Pharmacol (1984) 0.95
Systemic distribution of beta 2-microglobulin-derived amyloidosis in patients who undergo long-term hemodialysis. Report of seven cases and review of the literature. Arch Pathol Lab Med (1994) 0.94
Haemodialysis arteriovenous access--a prospective haemodynamic evaluation. Nephrol Dial Transplant (1996) 0.94
Threshold Amsler grid as a screening tool for asymptomatic patients on hydroxychloroquine therapy. Br J Ophthalmol (2005) 0.91
A method for obtaining high recovery of purified subcellular fractions of rat liver homogenate. Anal Biochem (1982) 0.91
Postoperative rhabdomyolysis in patients with end-stage renal failure. Am J Kidney Dis (1998) 0.88
Prostaglandin E2 and cyclic AMP in tumor and plasma of breast cancer patients. J Cancer Res Clin Oncol (1981) 0.88
Activity of porphobilinogen deaminase in peripheral blood mononuclear cells of patients with metastatic cancer. Cancer (1988) 0.87
MRI and CT in the differential diagnosis of pleural disease. Chest (2000) 0.85
Surgery in chronic dialysis patients. Isr J Med Sci (1995) 0.85
Absorption, distribution and elimination of fumonisin B(1) metabolites in weaned piglets. Food Addit Contam Part A Chem Anal Control Expo Risk Assess (2008) 0.84
Platelet count and thrombopoietic activity in patients with chronic renal failure. Nephron (1987) 0.84
The effects of succinylacetone (4,6-dioxoheptanoic acid) on delta-aminolevulinate synthase activity and the content of heme in monolayers of chick embryo liver cells. Biochim Biophys Acta (1982) 0.84
Lead poisoning: a new biochemical perspective on the differentiation between acquired and hereditary neuroporphyria. Clin Chem (2001) 0.84
Excretion of epidermal growth factor in human adult polycystic kidney disease. Isr J Med Sci (1997) 0.84
Erythrocytosis associated with renal artery thrombosis in a patient with polycystic kidney disease on hemodialysis. Acta Haematol (1990) 0.83
Anatomic sites of foot lesions resulting in amputation among diabetics and non-diabetics. Am J Phys Med Rehabil (1995) 0.83
Growth rate determines activity of porphobilinogen deaminase both in nonmalignant and malignant cell lines. Biochem Med Metab Biol (1988) 0.82
The role of calcium in human lymphocyte DNA repair ability. J Lab Clin Med (1997) 0.82
Clinical findings in 715 patients with newly detected pulmonary sarcoidosis--results of a cooperative study in former West Germany and Switzerland. WATL Study Group. Wissenschaftliche Arbeitsgemeinschaft für die Therapie von Lungenkrankheitan. Sarcoidosis Vasc Diffuse Lung Dis (1998) 0.81
Individualized workup: a new approach to the biochemical diagnosis of acute attacks of neuroporphyria. Physiol Res (2006) 0.81
Cutaneous photosensitivity induced by paclitaxel and trastuzumab therapy associated with aberrations in the biosynthesis of porphyrins. J Dermatolog Treat (2005) 0.81
Erythrocyte uroporphyrinogen synthase activity as a possible diagnostic aid in the diagnosis of lymphoproliferative diseases. Cancer (1983) 0.81
The porphyrogenic effects of calcium channel blocking drugs. Clin Sci (Lond) (1985) 0.80
Celiac territory ischemic syndrome in a patient on chronic hemodialysis. Clin Nephrol (2007) 0.80
Serum potassium levels and atrial fibrillation in haemodialysis patients. Nephrol Dial Transplant (2001) 0.80
Prostaglandin E2 and cyclic nucleotides in plasma and urine of colonic cancer patients. J Cancer Res Clin Oncol (1985) 0.79
Biochemical and molecular diagnosis of erythropoietic protoporphyria in an Ashkenazi Jewish family. J Inherit Metab Dis (2008) 0.79
The effect of agents blocking adrenergic beta-receptors on incorporation of amino acids into protein in tissue cultures of chick embryo liver cells. Biochem Pharmacol (1977) 0.79
Red blood cell calcium homeostasis in patients with end-stage renal disease. J Lab Clin Med (1989) 0.79
High-performance liquid chromatographic detection of pitfalls in porphobilinogen deaminase determination. J Chromatogr (1991) 0.79
Haemolysis in haemodialysis patients: evidence for impaired defence mechanisms against oxidative stress. Nephrol Dial Transplant (2000) 0.79
CAPD peritonitis--initial presentation as an acute abdomen with a clear peritoneal effluent. Clin Nephrol (1992) 0.79
Immunologic alterations in MRL/lpr mice after chronic dimethyl sulfoxide administration. Int J Immunopharmacol (1987) 0.79
A homoallelic FECH mutation in a patient with both erythropoietic protoporphyria and palmar keratoderma. J Eur Acad Dermatol Venereol (2010) 0.78
Uninephrectomy aggravates tubulointerstitial injury in rats with adriamycin nephrosis. Nephron (1994) 0.78
The influence of carbamazepine on the heme biosynthetic pathway. Biochem Med (1985) 0.78
Evidence for the interference of aluminum with bacterial porphyrin biosynthesis. Biometals (1994) 0.78
Adenocarcinoma at ureterosigmoidostomy junction in a renal transplant recipient 15 years after conversion to ileal conduit. Clin Nephrol (1995) 0.78
Neuroleptic malignant syndrome during perphenazine treatment in a patient with head and neck cancer: a case report. Otolaryngol Head Neck Surg (1992) 0.78
H2O2 induces DNA repair in mononuclear cells: evidence for association with cytosolic Ca2+ fluxes. J Lab Clin Med (1999) 0.78
Parathyroid hormone effect on the fragility of human young and old red blood cells in uremia. Nephron (1986) 0.77
Transformation, growth rate, and the heme biosynthetic pathway in V-abl-transfected fibroblasts. Biochem Med Metab Biol (1994) 0.77
Effect of immunosuppressive therapy on DNA repair and cancer incidence in renal transplant recipients. Transplant Proc (2000) 0.77
Non-cardiac use of nitroglycerin patches. Eur Heart J (1988) 0.77
Effects of erythropoietin on glucose tolerance in hemodialysis patients. Clin Nephrol (1994) 0.77
Variations in the length of poly-C and poly-T tracts in intron 3 of the human ferrochelatase gene. Cell Mol Biol (Noisy-le-grand) (2009) 0.77
Evidence of abnormality of lymphocyte uroporphyrinogen synthase in family members of patients with lymphoproliferative diseases. Cancer Lett (1985) 0.77
Biochemical changes associated with the osmotic fragility of young and mature erythrocytes caused by parathyroid hormone in relation to the uremic syndrome. Clin Biochem (1987) 0.77
Red blood cell calcium level in chronic renal failure: effect of continuous ambulatory peritoneal dialysis. J Lab Clin Med (1990) 0.77
Resistant hypertension associated with a renin-producing ovarian Sertoli cell tumor. Am J Clin Pathol (1986) 0.77
Sialyltransferase activity and sialic acid levels in multiple myeloma and monoclonal gammopathy. Eur J Haematol (1989) 0.77
Impaired DNA repair in patients with end-stage renal disease and its improvement with hemodialysis. Miner Electrolyte Metab (1991) 0.77
Plasma lipid profile in verapamil-treated hypertensive patients. Int J Clin Pharmacol Ther Toxicol (1987) 0.77
Impaired lymphocyte calcium metabolism in end-stage renal disease: enhanced influx, decreased efflux, and reduced response to mitogen. J Lab Clin Med (1999) 0.77
Sonographic features of dialysis-related amyloidosis of the shoulder. J Ultrasound Med (2000) 0.76
Effect of enalapril on the microvascular albumin leakage in patients with diabetic microangiopathy and normal or mildly elevated blood pressure. Clin Nephrol (1994) 0.76
Awareness is the name of the game: clinical and biochemical evaluation of a case of a girl diagnosed with acute intermittent porphyria associated with autism. Cell Mol Biol (Noisy-le-grand) (2009) 0.76
Accelerated heme synthesis and degradation in transformed fibroblasts. Biochem Med Metab Biol (1990) 0.76
A reliable diagnosis of porphyria should precede any conclusion concerning the safety of a drug in porphyria. Anesthesiology (1999) 0.75
Clinical problem-solving: necrotizing fasciitis. N Engl J Med (1994) 0.75
Brown tumours and secondary hyperparathyroidism--a continuing saga. Nephrol Dial Transplant (1996) 0.75
Hepatitis C infection in renal transplant recipients in Israel. Transplant Proc (1997) 0.75
[Mechanism of action of beta-blocking agents in porphyria]. Harefuah (1977) 0.75
The influence of propranolol on the concentration of heme and on the activity of delta aminolevulinate synthase in monolayers of chick embryo liver cells. Biochem Pharmacol (1982) 0.75
Favourable effect of intravenous propranolol in acute intermittent porphyria. Monogr Hum Genet (1978) 0.75
Clomipramine-induced pheochromocytoma crisis: a near fatal complication of a tricyclic antidepressant. J Clin Psychopharmacol (1997) 0.75
Effects of propranolol during pregnancy and development of rats. I. Adverse effects during pregnancy. Pediatr Res (1978) 0.75
An in vitro model demonstrating the glucose effect and the influence of fasting on porphyrin metabolism. FEBS Lett (1982) 0.75
Effect of prolonged fasting on heme metabolism in the rat. Isr J Med Sci (1984) 0.75
Inhibitory effect of membrane active compounds on the uptake of 14C-alpha-aminoisobutyric acid (AIB) in cultured chick embryo liver cells. Life Sci (1977) 0.75
Inhibitory effect of membrane active compounds on induction of tyrosine aminotransferase in chick embryo liver cells in culture. FEBS Lett (1977) 0.75
Inhibitory effect of some membrane active drugs on RNA and DNA synthesis in cultured chick embryo liver cells. Biochem Biophys Res Commun (1976) 0.75
Evidence relating the inhibitory effect of cobalt on the activity of delta-aminolevulinate synthase to the intracellular concentration of porphyrins. Biochem Pharmacol (1983) 0.75
The effect of beta-adrenergic blocking agents on experimental porphyria induced by 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC) in vivo and in vitro. Biochim Biophys Acta (1976) 0.75